Effect of Immunotherapy on Late Elderly Patients With Unresectable Hepatocellular Carcinoma: A Real‐World Clinical Study

Effect of Immunotherapy on Late Elderly Patients With Unresectable Hepatocellular Carcinoma: A Real‐World Clinical Study

ABSTRACT Background/Aim The global aging population includes an increasing number of elderly patients with hepatocellular carcinoma (HCC). This study aimed to clarify the real‐world outcomes, prognostic factors, and appropriate administration indicators for immunotherapy in elderly HCC patients. Met...

Full description

Saved in:
Bibliographic Details
Main Authors: Shun Kaneko, Yasuhiro Asahina, Miyako Murakawa, Shunsuke Ueyama, Hideki Watanabe, Chiaki Maeyashiki, Akiko Kusano‐Kitazume, Ayako Sato, Kozue Uchidate, Taro Watabe, Takehito Asakawa, Sho Watanabe, Junko Fujiki, Isamu Shibata, Shinya Oooka, Hitoshi Kurata, Mao Tsuchiya, Takashi Fujii, Keiichi Akahoshi, Daisuke Ban, Kento Inada, Tsubasa Nobusawa, Tomohiro Mochida, Keiya Watakabe, Taro Shimizu, Jun Tsuchiya, Masato Miyoshi, Fukiko Kawai‐Kitahata, Sayuri Nitta, Mina Nakagawa, Sei Kakinuma, Ryuichi Okamoto, Ochanomizu Liver Conference Study Group
Format: Article
Language:English
Published: Wiley 2025-09-01
Series:Cancer Medicine
Subjects:
ALBI score
atezolizumab plus bevacizumab
durvalumab‐tremelimumab
hepatocellular carcinoma
post‐ICI treatment
Online Access:https://doi.org/10.1002/cam4.71171
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.71171

Similar Items